INTERLEUKIN-2 AFTER AUTOLOGOUS BONE-MARROW TRANSPLANTATION AS CONSOLIDATIVE IMMUNOTHERAPY AGAINST MINIMAL RESIDUAL DISEASE

被引：0
|
作者：
BOSLY, A
BRICE, P
HUMBLET, Y
DOYEN, C
FAILLE, A
CHATELAIN, B
FRANKS, C
GISSELBRECHT, C
SYMANN, M
机构：
[1] UNIV CATHOLIQUE LOUVAIN, ONCOL & HEMATOL EXPTL LAB, BRUSSELS, BELGIUM
[2] EUROCETUS, AMSTERDAM, NETHERLANDS
来源：
NOUVELLE REVUE FRANCAISE D HEMATOLOGIE | 1990年 / 32卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：13 / 16
页数：4
相关论文
共 50 条
  • [1] INTERLEUKIN-2+/-LYMPHOCYTES AS CONSOLIDATIVE IMMUNOTHERAPY AFTER AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR HEMATOLOGIC MALIGNANCIES
    FEFER, A
    BENYUNES, M
    HIGUCHI, C
    YORK, A
    MASSUMOTO, C
    LINDGREN, C
    BUCKNER, CD
    THOMPSON, JA
    ACTA HAEMATOLOGICA, 1993, 89 : 2 - 7
  • [2] CONSOLIDATIVE IMMUNOTHERAPY AFTER AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR HEMATOLOGIC MALIGNANCIES
    BENYUNES, M
    YORK, A
    LINDGREN, C
    HIGUCHI, C
    THOMPSON, JA
    BUCKNER, CD
    FEFER, A
    CLINICAL RESEARCH, 1992, 40 (02): : A171 - A171
  • [3] IMMUNOTHERAPY OF MINIMAL RESIDUAL DISEASE IN CONJUNCTION WITH AUTOLOGOUS AND ALLOGENEIC BONE-MARROW TRANSPLANTATION (BMT)
    SLAVIN, S
    OR, R
    KAPELUSHNIK, Y
    DRAKOS, P
    ACKERSTEIN, A
    VOURKAKARUSSIS, U
    WEISS, L
    NAGLER, A
    LEUKEMIA, 1992, 6 : 164 - 166
  • [4] INTERLEUKIN-2 WITH OR WITHOUT LYMPHOKINE-ACTIVATED KILLER-CELLS AS CONSOLIDATIVE IMMUNOTHERAPY AFTER AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR ACUTE MYELOGENOUS LEUKEMIA
    BENYUNES, MC
    MASSUMOTO, C
    YORK, A
    HIGUCHI, CM
    BUCKNER, CD
    THOMPSON, JA
    PETERSEN, FB
    FEFER, A
    BONE MARROW TRANSPLANTATION, 1993, 12 (02) : 159 - 163
  • [5] INTERLEUKIN-2 THERAPY AFTER AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR HEMATOLOGIC MALIGNANCIES
    FEFER, A
    BENYUNES, MC
    MASSUMOTO, C
    HIGUCHI, C
    YORK, A
    BUCKNER, CD
    THOMPSON, JA
    SEMINARS IN ONCOLOGY, 1993, 20 (06) : 41 - 45
  • [6] INTERLEUKIN-2 IMMUNOTHERAPY IN CHILDREN WITH NEUROBLASTOMA AFTER HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS BONE-MARROW TRANSPLANTATION
    FAVROT, MC
    MICHON, J
    FLORET, D
    COCHAT, C
    NEGRIER, S
    MATHIOT, C
    COZE, C
    ZUCKER, JM
    FRANKS, CR
    BOUFFET, E
    PHILIP, T
    PEDIATRIC HEMATOLOGY AND ONCOLOGY, 1990, 7 (03) : 275 - 284
  • [7] AUTOLOGOUS BONE-MARROW TRANSPLANTATION (ABMT) WITH INTERLEUKIN-2 (IL-2) - ACTIVATED BONE-MARROW
    CHARAK, B
    VERMA, U
    CAHILL, R
    MAZUMDER, A
    BLOOD, 1993, 82 (10) : A628 - A628
  • [8] INTERLEUKIN-2 INFUSION AFTER AUTOLOGOUS BONE-MARROW TRANSPLANTATION ENHANCES HEMATOPOIETIC REGENERATION
    HESLOP, HE
    DUNCOMBE, AS
    REITTIE, JE
    BELLOFERNANDEZ, C
    GOTTLIEB, DJ
    PRENTICE, HG
    HOFFBRAND, AV
    BRENNER, MK
    TRANSPLANTATION PROCEEDINGS, 1991, 23 (01) : 1704 - 1705
  • [9] LYMPHOCYTES-IL2+/- AS CONSOLIDATIVE IMMUNOTHERAPY AFTER AUTOLOGOUS BONE-MARROW TRANSPLANTATION (ABMT) FOR HEMATOLOGIC MALIGNANCIES
    FEFER, A
    BENYUNES, M
    HIGUCHI, C
    YORK, A
    MASSUMOTO, C
    LINDGREN, C
    BUCKNER, CD
    THOMPSON, JA
    BRITISH JOURNAL OF HAEMATOLOGY, 1992, 82 (01) : 285 - 286
  • [10] Interleukin-2 (IL-2) as a consolidative treatment after autologous bone marrow transplantation for hematologic malignancies.
    Massumoto, C
    Ostronoff, M
    Macedo, MCMA
    ZAmbon, E
    Medeiros, RSS
    DorlhiacLlacer, PE
    Chamone, DAF
    Dulley, F
    BLOOD, 1995, 86 (10) : 3817 - 3817
12345